Redwood City, CANCT07266402Now EnrollingIRB Ready

Chronic Inducible Urticaria Clinical Trial in Redwood City, CA

Access cutting-edge chronic inducible urticaria treatment through this clinical trial at a research site in Redwood City. Study-provided care at no cost to qualified participants.

Sponsored by Celldex Therapeutics

Quick Self-Assessment

See if you qualify for this Redwood City location

Preparing your pre-screening questions…

Expert Care in Redwood City

Access chronic inducible urticaria specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic inducible urticaria treatment provided free

Apply for This Redwood City Location

Check if you qualify for this chronic inducible urticaria clinical trial in Redwood City, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Redwood City

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Redwood City site if eligible
  4. 4Begin participation

About This Chronic Inducible Urticaria Study in Redwood City

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.

Sponsor: Celldex Therapeutics

Who Can Participate

Inclusion Criteria

Males and females, \>/= 18 years of age.
Diagnosis of cold induced urticaria or symptomatic dermographism \>/= 3 months.
Diagnosis of cold induced urticaria or symptomatic dermographism despite the use of a stable regimen of second generation non-sedating H1-antihistamine as defined by:
The presence of hives for \>/= 6 weeks at any time prior to Visit 1 despite the use of H1-antihistamines.
Must be on a stable regimen of second generation non-sedating H1-antihistamine for \>/= 4 weeks prior to study treatment.
Cold induced urticaria: A Critical Threshold Temperature (CTT) of ≥ 15 °C and \< 37 °C using the TempTest® and a numerical rating scale score of ≥ 5 for itch after the provocation test.
Symptomatic dermographism: A Critical Friction Threshold (CFT) of ≥ 3 using the FricTest® and a numerical rating scale score of ≥ 5 for itch after the provocation test.
Cold induced urticaria: Positive ice-cube test resulting in hives at the provocation site during Screening
Normal blood counts and liver function tests.
Both males and females of child-bearing potential must agree to use highly effective contraceptives during the study and for ≥ 150 days after treatment.
Willing and able to complete a daily symptom electronic diary and comply with study visits.
Participants with and without prior biologic experience are eligible. Key

Exclusion Criteria

Women who are pregnant or nursing.
Clearly defined cause for chronic urticaria.
Active, pruritic skin condition in addition to cold induced urticaria or symptomatic dermographism.
Medical condition that would cause additional risk or interfere with study procedures.
Known HIV, hepatitis B or hepatitis C infection.
Vaccination with a live vaccine within 30 days prior to screening (subjects must agree to avoid vaccination with a live vaccine during the study). Inactivated vaccines are allowed such as seasonal influenza injection or COVID-19 vaccine.
History of anaphylaxis, unless due to cold exposure over a large part of the body (such as swimming in cold water).
Prior treatment with barzolvolimab There are additional criteria that your study doctor will review with you to confirm you are eligible for the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Redwood City?

Yes, this clinical trial (NCT07266402) has an active research site in Redwood City, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Inducible Urticaria Treatment Options in Redwood City, CA

If you're searching for chronic inducible urticaria treatment options in Redwood City, CA, this clinical trial (NCT07266402) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Redwood City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inducible urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic inducible urticaria clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Redwood City, CA

See all ulcerative colitis clinical trials recruiting in Redwood City — not just this study.

Browse Ulcerative Colitis Trials in Redwood City

Ready to Join in Redwood City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Redwood City, CA